%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Takalay, S.
%A Ngo-Giang-Huong, Nicole
%A Kongnim, W.
%A Mongkolwat, P.
%A Phoseng, P.
%A Wangsaeng, N.
%A Hongjaisee, S.
%A Butr-Indr, B.
%A Tragoolpua, K.
%A Jourdain, Gonzague
%A Pornprasert, S.
%A Khamduang, W.
%T Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 among at-risk populations in Chiang Mai and Lamphun provinces, Thailand, during November 2020-January 2021
%D 2022
%L fdi:010084610
%G ENG
%J PLoS One
%@ 1932-6203
%K THAILANDE
%K CHIANG MAI PROVINCE ; LAMPHUN PROVINCE
%M ISI:000775890100049
%N 2
%P e0263127 [12 ]
%R 10.1371/journal.pone.0263127
%U https://www.documentation.ird.fr/hor/fdi:010084610
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2022-05/010084610.pdf
%V 17
%W Horizon (IRD)
%X Non-healthcare workers with a high potential for exposure to severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) may contribute to the virus spreading. Data among asymptomatic and high exposure risk populations is still scarce, in particular Chiang Mai and Lamphun provinces, Thailand. We conducted a cross-sectional observational study aiming to assess the prevalence of SARS-CoV-2 RNA positivity, anti-SARS-CoV-2 IgM/IgG, and potential associated factors among asymptomatic/mild symptomatic individuals with a high exposure risk in Chiang Mai and Lamphun provinces, during the second wave of outbreak in Thailand (November 2020-January 2021). Socio-demographic data was collected through an on-line questionnaire prior to collection of nasopharyngeal/throat swab samples and blood samples tested for SARS-CoV-2 RNA (DaAn Gene, China) and anti-SARS-CoV-2 IgM/IgG antibodies (commercial lateral flow immunoassays), respectively. Univariable and multivariable logistic regression analysis were used to analyze associated factors. None of 1,651 participants were found positive for SARS-CoV-2 RNA (0%, 95% confidence intervals, CI: 0-0.2). Fourteen were positive for anti-SARS-CoV-2 IgM/IgG antibodies (0.9%, 95% CI: 0.5-1.4), including 7 positives for IgM and 7 positives for IgG (0.4%, 95% CI: 0.2-0.9). Being over 50 years old was independently associated with virus exposure (OR: 5.8, 95% CI: 1.0-32.1%, p = 0.045). Despite high exposure risk, no current infection was found, and a very high proportion was still susceptible to SARS-CoV-2 infection and would clearly benefit from vaccination. Continuing active surveillance, rolling out of vaccination and monitoring response to vaccine will help better control the COVID-19 spread.
%$ 052 ; 050